Drug intelligence / Profile preview

Systane Nighttime Tears Again Ointment + miconazole nitrate + zinc oxide

Development stage
Unknown
Lead developer
Alcon
Modality
Small Molecules
Administration
Topical, Ophthalmic
01

Overview

This entity represents a combination of two ophthalmic lubricant brands, Systane Nighttime and Tears Again Ointment, with the antifungal agent miconazole nitrate and the skin protectant zinc oxide. Systane Nighttime and Tears Again Ointment are typically formulated with white petrolatum and mineral oil to provide an occlusive barrier that prevents moisture loss from the ocular surface, treating symptoms of dry eye. Miconazole nitrate is an imidazole antifungal that inhibits the synthesis of ergosterol by targeting the fungal enzyme lanosterol 14-alpha-demethylase, thereby disrupting cell membrane integrity. Zinc oxide serves as a mild astringent and topical barrier, commonly used to treat or prevent skin irritation. The inclusion of zinc oxide, which is generally not used in ophthalmic preparations due to potential irritation, suggests this combination may be a list of separate products or a specific compounded topical formulation rather than a standard commercial ophthalmic drug.

Brand names
Systane NighttimeTears Again Ointment
Other names
miconazole nitrate + zinc oxide + white petrolatum + mineral oil
02

Targets

CYP51A1 (Sterol 14α-demethylase)

Beyond the preview

Go deeper on Systane Nighttime Tears Again Ointment + miconazole nitrate + zinc oxide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Systane Nighttime Tears Again Ointment + miconazole nitrate + zinc oxide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call